Materials is an esteemed journal published by MDPI, dedicated to advancing the fields of Condensed Matter Physics and Materials Science. With its commitment to Open Access since its inception in 2008, the journal has made significant strides in disseminating high-quality research globally, allowing researchers, professionals, and students easy access to cutting-edge studies without financial barriers. Hailing from Switzerland, the journal has shown remarkable growth and prominence, currently ranked in the Q2 quartile in its categories according to the latest assessments, which highlights its impact within the community. As the journal converges its focus from 2008 to 2024, it aims to continually foster a robust exchange of knowledge on innovative materials and their applications, thereby supporting the evolving landscape of science and technology. With an E-ISSN of 1996-1944 and a user-friendly platform, Materials is poised to be a leading choice for scholars eager to contribute to and engage with pioneering research.

ACS Biomaterials Science & Engineering, published by the American Chemical Society, serves as a premier platform for the latest advancements and research in the fields of biomaterials and biomedical engineering. With an impressive impact factor and a strong reputation reflected in its ranking—Q2 in Biomaterials and Q1 in Biomedical Engineering—the journal attracts a diverse and engaged readership. Since its inception in 2015, it has aimed to foster innovation by publishing high-quality research articles, reviews, and perspectives on the synthesis, characterization, and application of biomaterials. Researchers and professionals benefit from the journal's rigorous peer-review process and its focus on translational science, making it essential for those looking to stay at the forefront of biomaterials research. Located in Washington, DC, USA, the journal plays a pivotal role in connecting academic and industrial sectors, ultimately driving advancements that impact biomedicine and related fields.

Current Opinion in Biomedical Engineering is a renowned journal published by Elsevier, focusing on the cutting-edge developments and critical assessments in the fields of biomedical engineering and related disciplines. With an ISSN of 2468-4511, it provides a valuable platform for researchers and professionals to disseminate their insights and discoveries in areas such as bioengineering, biomaterials, and medicine. Its impressive impact factor positions it in the Q2 category for several fields, including Bioengineering and Biomedical Engineering, highlighting its influence and relevance in ongoing scientific dialogues. The journal’s unique format of opinion pieces and reviews encourages innovative thinking and fosters collaboration among experts. As an essential resource for those engaged in the life sciences and engineering, Current Opinion in Biomedical Engineering serves to stimulate discussion, promote knowledge exchange, and drive advancements in biomedical applications. Set in the Netherlands at Radarweg 29, 1043 NX Amsterdam, the journal is accessible through various academic platforms, enabling a global readership to engage with the latest scholarly work in this dynamic field.

Advanced Biology, published by WILEY-V C H VERLAG GMBH, serves as a premier platform where innovative research and scientific breakthroughs in the fields of biochemistry, genetics, and molecular biology converge. Established in 2021, this journal has rapidly ascended to prominence, securing Q1 rankings in its primary categories, including general biochemistry and biomedical engineering, and a solid Q2 ranking in biomaterials. With an ISSN of 2701-0198 and an emphasis on open access, Advanced Biology ensures that rigorous peer-reviewed research is accessible to a global audience, enhancing visibility and fostering collaboration among researchers, professionals, and students alike. By 2024, it aims to continually elevate scientific understanding and innovation, catering to the growing interdisciplinary nature of these critical fields. With Scopus rankings placing it amongst the top quartiles in its disciplines, Advanced Biology is poised to make significant contributions to the future of life sciences.

Tissue Engineering Part A is a prestigious peer-reviewed journal published by MARY ANN LIEBERT, INC that focuses on innovative research and advancements within the field of tissue engineering and regenerative medicine. Since its inception in 2008, this journal has played a critical role in disseminating cutting-edge findings that bridge the gap between laboratory research and clinical application, underscoring its significance in the scientific community. With a diverse scope encompassing biochemistry, bioengineering, biomaterials, and biomedical engineering, the journal ranks notably in the Scopus database, holding a Q2 quartile status across multiple categories, thus reflecting its high impact on ongoing research and professional practice. For researchers, professionals, and students, Tissue Engineering Part A serves as an invaluable resource, offering insights into the latest methodologies and breakthroughs that drive the future of healthcare and therapeutic strategies. While primarily a subscription-based journal, it ensures that vital research is accessible to a broad audience of scientists and engineers committed to advancing the life sciences.

Biomedical Materials, published by IOP Publishing Ltd, is a premier journal dedicated to the rapidly evolving field of biomedical engineering and materials science. With a robust impact factor showcasing its influence, this journal serves as a vital platform for disseminating pioneering research from 2006 to 2024. Covering an array of interdisciplinary topics—ranging from biomaterials to bioengineering and applied chemistry—the journal consistently ranks in the second quartile across multiple categories including Bioengineering (Q2), Biomaterials (Q2), and Biomedical Engineering (Q2) as of 2023. Researchers, professionals, and students alike benefit from its contributions, exploring innovative solutions at the intersection of biology and material science. Although not an Open Access journal, Biomedical Materials remains essential in advancing our understanding and facilitating discussions surrounding state-of-the-art materials that revolutionize medical applications and enhance patient care.

BIOMEDICAL MICRODEVICES is a leading journal published by Springer that focuses on the innovative field of microdevices within biomedical engineering. With an ISSN of 1387-2176 and an E-ISSN of 1572-8781, BIOMEDICAL MICRODEVICES offers a prestigious platform for researchers to disseminate their findings from 1998 to 2024, demonstrating a long-standing commitment to advancing knowledge in this critical area. The journal is recognized for its significant contributions, boasting a Q2 ranking in Biomedical Engineering and Nanoscience and Nanotechnology, and a Q3 rank in Molecular Biology. Renowned for its rigorous peer-review process, it is positioned within the top 30% of its field according to Scopus rankings, making it a valuable resource for researchers and practitioners alike. Though it operates under a subscription model, the emphasis on quality and relevance within its scope ensures that BIOMEDICAL MICRODEVICES remains a vital source of cutting-edge research that bridges engineering and biological systems, fostering innovation and collaboration in the pursuit of novel health solutions.

Bio-Design and Manufacturing, published by SPRINGER HEIDELBERG, is a pioneering journal that stands at the forefront of innovation in the fields of Biomedical Engineering, Biotechnology, Industrial and Manufacturing Engineering, and Materials Science. With its ISSN 2096-5524 and E-ISSN 2522-8552, this journal has established itself as a leading platform for disseminating cutting-edge research and advancements that merge biological principles with manufacturing processes, emphasizing sustainable and efficient practices. It has garnered recognition in the 2023 category quartiles, boasting a Q1 rank in all its relevant fields, which underscores its significance and impact—evident from its prime Scopus rankings that place it within the top percentiles of numerous engineering and materials science disciplines. Researchers, professionals, and students alike benefit from the wealth of knowledge presented in this journal, making it an essential resource for those seeking to enhance their understanding of bio-design applications and innovation in manufacturing processes.

JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE is a leading peer-reviewed journal published by Springer, dedicated to advancing the field of biomedical materials science. With an ISSN of 0957-4530 and E-ISSN 1573-4838, this Open Access journal has been committed to providing researchers and professionals with freely accessible, high-quality research since 2021. It features an extensive scope spanning bioengineering, biomaterials, biomedical engineering, and biophysics, reflecting its significant impact within these interdisciplinary domains. Recognized within the Q2 category of the 2023 rankings in multiple fields, the journal proudly positions itself as a crucial resource for innovative materials that contribute to advancements in medical applications. With impressive Scopus rankings, including 26th in Biophysics and 40th in Materials Science for Biomaterials, researchers, students, and industry professionals alike can rely on this publication for cutting-edge insights that drive the future of medical materials and technologies. Based in Dordrecht, Netherlands, the journal provides a vibrant platform for sharing groundbreaking discoveries and fostering collaborative research among a global audience.

Regenerative Medicine, published by Taylor & Francis Ltd, is a pivotal journal within the field of biomedical research, focusing on the innovative advances in regenerative and restored functions in human health. With an ISSN of 1746-0751 and an E-ISSN of 1746-076X, this esteemed journal boasts a commendable impact factor within its categories, notably holding the Q2 status in Embryology and Q3 in Biomedical Engineering as of 2023. Covering a broad spectrum of topics from stem cell research to tissue engineering, it serves as a crucial platform for interdisciplinary collaboration among researchers, professionals, and students dedicated to the regeneration of tissues and organs. Given its comprehensive scope from 2006 to 2024, the journal continues to attract high-quality manuscripts that advance the frontiers of knowledge in regenerative medicine. Researchers and practitioners alike are encouraged to engage with the latest findings and methodologies disseminated in this vital publication.